Europe — EMA
Mоксогамма, Moxogamma (Moxonidine)
GNH USA supplies Mоксогамма (Moxonidine), an imidazoline receptor agonist for essential hypertension. Request a quote for global supply.
Request sourcing
What is Moxonidine?
Moxonidine, the active ingredient in Mоксогамма, Moxogamma, is an imidazoline receptor agonist presented as an oral tablet for oral use. It treats essential hypertension in adults by lowering blood pressure. GNH USA supplies Mоксогамма, Moxogamma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Moxonidine used for?
Moxonidine is used in the management of essential hypertension, a condition characterized by elevated systemic blood pressure.
Essential hypertension: reduces systolic and diastolic blood pressure. Hypertension with increased sympathetic activity: decreases sympathetic outflow to lower vascular resistance. High blood pressure in adults: assists in achieving target blood pressure levels.
What are the side effects of Moxonidine?
Moxonidine may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Dizziness - Dry mouth - Fatigue - Headache - Nausea - Constipation
Serious or Rare Side Effects: - Severe hypotension - Bradycardia - Allergic reactions (rash, angioedema) - Hepatic dysfunction - Renal impairment - Syncope
What precautions apply to Moxonidine?
Before initiating therapy with Moxonidine, several safety considerations should be reviewed.
Renal impairment: adjust therapy with caution. Hepatic disease: monitor liver function regularly. Pregnancy: use only if clearly needed after risk assessment. Elderly: start with lower dose and monitor for hypotension. Concomitant antihypertensives: risk of additive hypotension. Store at ambient temperature: keep in the original container, protect from moisture and light.
What does Moxonidine interact with?
Moxonidine can interact with other medicines, affecting blood pressure control.
Major Interactions (Avoid): - Combined use with other central antihypertensives (e.g., clonidine): risk of excessive hypotension. - Potassium‑sparing diuretics: may enhance hypotensive effect. - Beta‑blockers: additive blood pressure lowering.
Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure for additive effects. - Calcium channel blockers: observe for dizziness or excessive lowering of pressure. - NSAIDs: may reduce antihypertensive efficacy, requiring dose adjustment.
